Literature DB >> 8099187

Safety of prophylactic tamoxifen.

D H Phillips, S Venitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8099187     DOI： 10.1016/0140-6736(93)90934-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Synthesis and Pharmacological Evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents.

Authors:  Madhavi Gangapuram; Suresh Eyunni; Kinfe K Redda
Journal:  J Cancer Sci Ther       Date:  2014-04-25

2.  In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs.

Authors:  Musiliyu A Musa; John S Cooperwood; M Omar F Khan; Taufiq Rahman
Journal:  Arch Pharm (Weinheim)       Date:  2010-11-29       Impact factor: 3.751

3.  In-vitro Antiproliferative Activity of New Tetrahydroisoquinolines (THIQs) on Ishikawa Cells and their 3D Pharmacophore Models.

Authors:  Suresh Kumar V K Eyunni; Madhavi Gangapuram; Kinfe K Redda
Journal:  Lett Drug Des Discov       Date:  2014       Impact factor: 1.150

Review 4.  Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases.

Authors:  Barbara Buonomo; Antonella Brunello; Stefania Noli; Loredana Miglietta; Lucia Del Mastro; Matteo Lambertini; Fedro Alessandro Peccatori
Journal:  Breast Care (Basel)       Date:  2019-07-25       Impact factor: 2.860

5.  Synthesis and Biological Evaluations of Ring Substituted Tetrahydroisoquinolines (THIQs) as Anti-Breast Cancer Agents.

Authors:  Suresh Vk Eyunni; Madhavi Gangapuram; Bereket Mochona; Nelly Mateeva; Kinfe K Redda
Journal:  J Cancer Sci Ther       Date:  2017-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.